Prevalence of DM | |||||
---|---|---|---|---|---|
Estimate | Study year | Sampling frame and sample | Study design | Diagnostic test and diagnostic criteria | Reference |
DM2: 2.1% (1992), 8.7% (1994), 7.3% (2006) | 2008 | Multiple sampling frames and samples | Multiple study designs | Multiple diagnostic test and criteria | [3] |
Overall: 6.8% | 1990 | Sampling frame: N/A | Cross-sectional | Diagnostic test: Self-reporting, population survey | [9] |
Sample: 12,041 households covering all age groups | Diagnostic criteria: N/A | ||||
Overall: 8.9% | 2003 | Sampling frame: two pilot villages | Cross-sectional | Diagnostic test: Fasting blood glucose | [10] |
Sample: 4,050 adults aged 25 to 64 years | Diagnostic criteria: American Diabetes Association (ADA): The person is treated for diabetes or has a glycaemia level >1.26 g/l | ||||
Overall: 2.1% | November-December 2005 | Sampling frame: Four regions: Central, South, East, West | Cross-sectional | Diagnostic test: Self-reporting, population survey | [11] |
Males: 1.9% | |||||
Females: 2.3% | |||||
Peak age group was 60+ (12.5%), followed by 35–59 (4.1%) and 25–34 (0.4%) | Sample: 25,919 females aged 15 to 49 years and 3,089 children under 5 years of age | Diagnostic criteria: N/A | |||
More prevalent in urban areas (2.6%) than in rural areas (1.5%) | |||||
More prevalent among the richest quintile (3.5%) than among the poorest quintile (1%) | |||||
Overall: 12.29% | June 2005 | Sampling frame: Three regions: Tell, High | Cross-sectional | Diagnostic test: Glucose testing | [12] |
Males: 11.93% | |||||
Females: 12.54% | Plateaus, South (Sahara) | Diagnostic criteria: N/A | |||
Peak age group was 60–64 (22.37%), followed by 65–70 (22.05%) and 55–59 (13.70%) | Sample: 4,818 adults aged 35 to 70 | ||||
More prevalent in urban areas (13.81%) than in rural areas (9.62%) | |||||
More prevalent in the High Plateaus (13.27%) than in the Tell (12.26%) or South (Sahara) (8.52%) | |||||
Overall: 14.2% | 2007 | Sampling frame: Tlemcen (in western Algeria) | Cross-sectional | Diagnostic test: Fasting blood sample | [16] |
Males: 20.4% | |||||
Females: 10.7% | Sample: 7,656 adults (2,799 males, 4,857 females) over 20 years of age | Diagnostic criteria: WHO (1985) | |||
DM1: 3.7% | |||||
DM2: 10.5% | |||||
More prevalent in urban areas (15.3%) than in rural (12.9%) areas | |||||
DM2: 8.2% | 2001 | Sampling frame: Setif (in eastern Algeria) | Cross-sectional | Diagnostic test: Oral glucose tolerance test | [17] |
7.3% urban vs. 9.7% rural | |||||
Sample: 1, 457 subjects aged 30 to 64 years | Diagnostic criteria: WHO | ||||
Overall prevalence: 13.8% | 2010 | Sampling frame: Central Algeria | Cross-sectional | Diagnostic test: N/A | [18] |
Sample: 1,036 children under 15 years of age (47.5% boys and 52.5% girls; age category distribution--12% (0–4 years), 34% (5–9 years) and 54% (10–14 years) | Diagnostic criteria: N/A | ||||
DM2: 1.3% | 2002 | Sampling frame: Adrar (in southern Algeria) | Cross-sectional | Diagnostic test: N/A | [19] |
Sample: 1,000 subjects | Diagnostic criteria: N/A |